Teemu Murtola

Activities

Activities per year 2006 2015 2017 2022

• 91 Conference presentation
• 37 Supervisor of licentiate candidate in medicine
• 10 Visit abroad
• 6 Invited lecture
• 12 More
  • 3 Position of trust in an academic community
  • 2 Evaluation of funding applications
  • 2 Pre-examination of dissertation or acting as opponent to doctoral students
  • 2 Position of trust in public sector
  • 1 Chair of workshop, panel, session or tutorial
  • 1 Membership of an organizing committee of a conference or seminar
  • 1 Public talk

Activities per year

Search results

• Eturauhassyöpäpotilaiden kokemukset ohjatusta liikuntaharjoittelusta hormonihoidon aikana

  Eeva Harju (Contributor), Teemu Murtola (Contributor) & Hanna Ojala (Contributor)

  30 Sep 2020

  Activity: Talk or presentation › Conference presentation

• Experiences of supervised resistance exercise in prostate cancer patients undergoing androgen deprivation therapy - a pilot study

  Eeva Harju (Speaker), Annastiina Hakulinen (Speaker), Annastiina Hakulinen (Speaker), Hanna Ojala (Speaker) & Teemu Murtola (Speaker)

  3 Oct 2019

  Activity: Talk or presentation › Conference presentation

• Association between NSAID, statins, and bisphosphonates and prostate cancer survival during androgen deprivation therapy in the Finnish Randomized Study of Prostate Cancer Screening

  Teemu Murtola (Contributor)

  17 Apr 2018

  Activity: Talk or presentation › Conference presentation

• Allopurinol and risk of benign prostatic hyperplasia in a Finnish population-based cohort

  Ville Kukko (Contributor), Antti Kaipia (Contributor), Kirsi Talala (Contributor), Taari Kimmo (Contributor), Teuvo Tammela (Contributor), Anssi Auvinen (Contributor) & Teemu Murtola (Contributor)

  19 Mar 2018

  Activity: Talk or presentation › Conference presentation

• Antidiabetic drugs and risk of benign prostatic hyperplasia

  Teuvo Tammela (Contributor), Anssi Auvinen (Contributor) & Teemu Murtola (Contributor)

  19 Mar 2018

  Activity: Talk or presentation › Conference presentation

• Neoadjuvant chemotherapy does not increase morbidity of radical cystectomy - a 10-year nationwide study

  Antti Salminen (Contributor), Teemu Murtola (Contributor) & Peter Boström (Contributor)

  18 Mar 2018

  Activity: Talk or presentation › Conference presentation

• Blood glucose balance and disease-specific survival after prostate cancer diagnosis in the Finnish Randomized Study of Prostate Cancer Screening

  Teemu Murtola (Contributor), Anssi Auvinen (Contributor) & Teuvo Tammela (Contributor)

  17 Mar 2018

  Activity: Talk or presentation › Conference presentation

• Bladder cancer survival in users of HDAC-inhibiting antiepileptic drugs in a population-based cohort study

  Teuvo Tammela (Contributor) & Teemu Murtola (Contributor)

  16 Mar 2018

  Activity: Talk or presentation › Conference presentation

• Statins and renal cancer prognosis in a Finnish population-based cohort

  Tommi Eskelinen (Contributor), Teuvo Tammela (Contributor), Andres Kotsar (Contributor) & Teemu Murtola (Contributor)

  16 Mar 2018

  Activity: Talk or presentation › Conference presentation

• Bladder cancer survival in men using 5-alpha-reductase inhibitors

  V Mäkelä (Speaker), A Kotsar (Speaker), T Tammela (Speaker) & T Murtola (Speaker)

  16 Mar 2018

  Activity: Talk or presentation › Conference presentation

• Bladder cancer survival in men using 5-alpha-reductase inhibitors

  Ville Mäkelä (Contributor), Andres Kotsar (Contributor), Teuvo Tammela (Contributor) & Teemu Murtola (Contributor)

  16 Mar 2018

  Activity: Talk or presentation › Conference presentation

• Statins and prognosis of renal cell cancer : a retrospective Finnish cohort study

  Teuvo Tammela (Contributor) & Teemu Murtola (Contributor)

  16 Mar 2018

  Activity: Talk or presentation › Conference presentation

• Bladder cancer survival in users of HDAC-inhibiting antiepileptic drugs in a population-based cohort study

  Teemu Murtola (Contributor)

  9 Mar 2018

  Activity: Talk or presentation › Conference presentation

• Rintasyövän levinneisyys ja ennuste diabeetikoilla suomalaisessa väestöpohjaisessa kohortissa

  Teemu Murtola (Speaker)

  17 Nov 2017

  Activity: Talk or presentation › Conference presentation

• Anticoagulants and cancer mortality in the Finnish Randomized Study of Screening for Prostate Cancer

  Teemu Murtola (Contributor)

  8 Nov 2017

  Activity: Talk or presentation › Conference presentation

• Anticoagulants and cancer mortality in the Finnish Randomized Study of Screening for Prostate Cancer

  Pete Kinnunen (Contributor), Teemu Murtola (Contributor), Kirsi Talala (Contributor), Taari Kimmo (Contributor), Teuvo Tammela (Contributor) & Anssi Auvinen (Contributor)

  8 Nov 2017

  Activity: Talk or presentation › Conference presentation

• Fasting blood glucose and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer

  Teemu Murtola (Speaker), Ville Vihervuori (Speaker), Jorma Lahtela (Speaker), Kirsi Talala (Speaker), Taari Kimmo (Speaker), Teuvo Tammela (Speaker) & Anssi Auvinen (Speaker)

  14 May 2017

  Activity: Talk or presentation › Conference presentation

• Atorvastatin and prostate cancer - a phase 2 clinical trial

  Teemu Murtola (Contributor)

  4 Apr 2017

  Activity: Talk or presentation › Conference presentation

• Breast cancer extent and survival in diabetic women in a Finnish population-based cohort

  Teemu Murtola (Contributor)

  4 Apr 2017

  Activity: Talk or presentation › Conference presentation

• Cancer mortality by antiarrhythmic drug use in a population-based cohort of Finnish men

  Teemu Murtola (Contributor)

  4 Apr 2017

  Activity: Talk or presentation › Conference presentation

• Statin use and prognosis of the upper tract urothelial carcinoma in a Finnish population-based cohort

  H Hurskainen (Contributor), A Kotsar (Contributor), T Tammela (Contributor) & T Murtola (Contributor)

  27 Mar 2017

  Activity: Talk or presentation › Conference presentation

• Upper tract urothelial carcinoma: stage and prognosis among statin users in a Finnish population-based cohort

  Teemu Murtola (Contributor)

  27 Mar 2017

  Activity: Talk or presentation › Conference presentation

• Risk of benign prostatic hyperplasia in users of non-steroidal anti-inflammatory drugs

  Teemu Murtola (Contributor), Lotta Nygård (Contributor), Kirsi Talala (Contributor), Taari Kimmo (Contributor), Teuvo Tammela (Contributor) & Anssi Auvinen (Contributor)

  26 Mar 2017

  Activity: Talk or presentation › Conference presentation

• The effect of non-steroidal anti-inflammatory drugs on risk of benign prostatic hyperplasia

  Teemu Murtola (Contributor), Anssi Auvinen (Contributor) & Teuvo Tammela (Contributor)

  26 Mar 2017

  Activity: Talk or presentation › Conference presentation

• Outcomes of PSA-based prostate cancer screening among men using non-steroidal anti-inflammatory drugs

  Teemu Murtola (Contributor), Anssi Auvinen (Contributor) & Teuvo Tammela (Contributor)

  25 Mar 2017

  Activity: Talk or presentation › Conference presentation

• Atorvastatin before prostatectomy and prostate cancer - a randomized, double-blind, placebo-controlled trial

  Teemu Murtola (Contributor), Tarja Heino-Tolonen (Contributor), Jarno Riikonen (Contributor), Heimo Syvälä (Contributor), Teemu Tolonen (Contributor), Juha Koskimäki (Contributor), Tomi Pakarainen (Contributor), Antti Kaipia (Contributor), Taina Isotalo (Contributor), Paula Kujala (Contributor) & Teuvo Tammela (Contributor)

  25 Mar 2017

  Activity: Talk or presentation › Conference presentation

• Neoadjuvant chemotherapy does not increase morbidity or mortality from radical cystectomy : 10-year national data from Finland with propensity score analyses

  Antti Salminen (Speaker), Iimari Koskinen (Speaker), Ileana Montoya Perez (Speaker), Saija Hurme (Speaker), Teemu Murtola (Speaker), Markku Vaarala (Speaker), Timo Nykopp (Speaker), Marjo Seppänen (Speaker), Taina Isotalo (Speaker), Timo Marttila (Speaker), Lasse Levomäki (Speaker), Sebastian Becker (Speaker), Mikael Anttinen (Speaker), Matti Säily (Speaker), Dimitri Pogodin-Hannolainen (Speaker), Jouko Viitanen (Speaker), Christian Palmberg (Speaker), Juhani Ottelin (Speaker), Jaakko Matomäki (Speaker), Jukka Sairanen (Speaker) & Peter Boström (Speaker)

  10 Feb 2017

  Activity: Talk or presentation › Conference presentation

• 5-alfareduktaasin estäjien käytön yhteys virtsarakkosyöpäkuoleman riskiin

  Teuvo Tammela (Speaker) & Teemu Murtola (Speaker)

  10 Feb 2017

  Activity: Talk or presentation › Conference presentation

• Atorvastatiinin lyhyen aikavälin vaikutus eturauhassyöpään : satunnaistettu, lumekontrolloitu ja kaksoissokkoutettu faasi 2 kliininen tutkimus

  Teemu Murtola (Speaker), Heimo Syvälä (Speaker) & Teuvo Tammela (Speaker)

  10 Feb 2017

  Activity: Talk or presentation › Conference presentation

• Statiinien käytön yhteys ylävirtsateiden uroteelikarsinooman levinneisyyteen ja ennusteeseen

  Teuvo Tammela (Speaker) & Teemu Murtola (Speaker)

  10 Feb 2017

  Activity: Talk or presentation › Conference presentation

• Virtsaputken sulkijaproteesileikkaukset virtsan ponnistuskarkailun hoitona kolmessa yliopistosairaalassa vuosina 2001 - 2013

  Teuvo Tammela (Speaker) & Teemu Murtola (Speaker)

  10 Feb 2017

  Activity: Talk or presentation › Conference presentation

• Prostate cancer incidence and cardiovascular mortality among users of testosterone replacement therapy in the Finnish Prostate Cancer Screening Trial

  Teemu Murtola (Contributor), Josefina Rytkönen (Contributor), Kirsi Talala (Contributor), Kimmo Taari (Contributor), Teuvo Tammela (Contributor) & Anssi Auvinen (Contributor)

  14 Mar 2016

  Activity: Talk or presentation › Conference presentation

• Prostate cancer incidence and cardiovascular mortality among users of testosterone replacement therapy in the Finnish Prostate Cancer Screening Trial

  Teemu Murtola (Contributor) & Teuvo Tammela (Contributor)

  11 Mar 2016

  Activity: Talk or presentation › Conference presentation

• Polymorphisms in genes of the glucose- and energy-metabolism pathways and prostate cancer: interplay with metformin

  Teemu Murtola (Contributor)

  15 May 2015

  Activity: Talk or presentation › Conference presentation

• Inflammation in benign prostate tissue and prostate cancer in the finasteride arm of the Prostate Cancer Prevention Trial

  Teemu Murtola (Contributor)

  15 May 2015

  Activity: Talk or presentation › Conference presentation

• 5-alpha reductase inhibitor use and prostate cancer survival in the Finnish Prostate Cancer Screening Trial

  Teemu Murtola (Contributor)

  21 Mar 2015

  Activity: Talk or presentation › Conference presentation

• Polymorphisms in genes of the glucose- and energy-metabolism pathways and prostate cancer: interplay with metformin

  Teemu Murtola (Contributor)

  21 Mar 2015

  Activity: Talk or presentation › Conference presentation

• Polymorphisms in genes of the glucose- and energy-metabolism pathways and prostate cancer : interplay with metformin

  Teemu Murtola (Contributor), Anssi Auvinen (Contributor), Antti Haring (Contributor), Johanna Schleutker (Contributor) & Teuvo Tammela (Contributor)

  20 Mar 2015

  Activity: Talk or presentation › Conference presentation

• 5-alpha reductase inhibitor use and prostate cancer survival in the Finnish Prostate Cancer Screening Trial

  T Murtola (Contributor), E Karppa (Contributor), K Taari (Contributor), T Tammela (Contributor) & A Auvinen (Contributor)

  20 Mar 2015

  Activity: Talk or presentation › Conference presentation

• Glukoosi- ja energiametabolian geenivarianttien yhteys eturauhassyöpään

  Teemu Murtola (Speaker), Tiina Wahlfors (Speaker), Antti Haring (Speaker), Taari Kimmo (Speaker), Ulf-Håkan Stenman (Speaker), Teuvo Tammela (Speaker), PRACTICAL konsortio (Speaker), Johanna Schleutker (Speaker) & Anssi Auvinen (Speaker)

  5 Feb 2015

  Activity: Talk or presentation › Conference presentation

• Tulehduskipulääkkeiden käyttö ja eturauhassyöpäpotilaiden eloonjääminen

  Thea Veitonmäki (Speaker), Teemu Murtola (Speaker), Liisa Määttänen (Speaker), Taari Kimmo (Speaker), Ulf-Håkan Stenman (Speaker), Teuvo Tammela (Speaker) & Anssi. Auvinen (Speaker)

  5 Feb 2015

  Activity: Talk or presentation › Conference presentation

• Rytmihäiriölääkkeet ja eturauhassyöpä suomalaisessa eturauhassyövän seulontatutkimuksessa

  Teemu Murtola (Speaker), Anssi Auvinen (Speaker), Liisa Määttänen (Speaker) & Teuvo Tammela (Speaker)

  5 Feb 2015

  Activity: Talk or presentation › Conference presentation

• Atorvastatiinin käytön vaikutus eturauhassyöpään - satunnaistettu, lumekontrolloitu kaksoissokkotutkimus

  Teemu Murtola (Speaker), Jarno Riikonen (Speaker), Juha Lönnroth (Speaker), Tomi Pakarainen (Speaker), Taina Isotalo (Speaker), Antti Kaipia (Speaker), Paula Kujala (Speaker), Heimo Syvälä (Speaker), Seppo Auriola (Speaker), Emma Raitoharju (Speaker), Terho Lehtimäki (Speaker) & Teuvo Tammela (Speaker)

  5 Feb 2015

  Activity: Talk or presentation › Conference presentation

• 5-alfareduktaasin inhibiittorien käytön yhteys eturauhassyöpäpotilaiden eloonjäämiseen

  Teemu Murtola (Speaker), Anssi Auvinen (Speaker) & Teuvo Tammela (Speaker)

  5 Feb 2015

  Activity: Talk or presentation › Conference presentation

• Diabeteslääkkeet ja eturauhassyöpäriski suomalaisessa eturauhassyövän seulontatutkimuksessa

  Antti Haring (Speaker), Anssi Auvinen (Speaker), Teemu Murtola (Speaker) & Teuvo Tammela (Speaker)

  5 Feb 2015

  Activity: Talk or presentation › Conference presentation

• Tulehduskipulääkkeiden käyttö ja eturauhassyöpäriski

  Teemu Murtola (Speaker), Anssi Auvinen (Speaker), Liisa Määttänen (Speaker) & Teuvo Tammela (Speaker)

  7 Feb 2014

  Activity: Talk or presentation › Conference presentation

• SNPs in genes of the glucose-metabolism pathway and prostate cancer: interplay with metformin

  TJ Murtola (Contributor), T Wahlfors (Contributor), A Haring (Contributor), K Taari (Contributor), UH Stenman (Contributor), TLJ Tammela (Contributor), L Määttänen (Contributor), J Schleutker (Contributor) & A. Auvinen (Contributor)

  29 Oct 2013

  Activity: Talk or presentation › Conference presentation

• Prostate cancer risk and anti-inflammatory drug use in the Finnish Prostate Cancer Screening Trial

  Teemu Murtola (Contributor)

  23 Aug 2013

  Activity: Talk or presentation › Conference presentation

• Prostate cancer risk among non-steroidal anti-inflammatory drug users in the Finnish prostate cancer screening trial

  Teemu Murtola (Contributor), Anssi Auvinen (Contributor) & Teuvo Tammela (Contributor)

  22 Aug 2013

  Activity: Talk or presentation › Conference presentation

• Polymorphisms in genes of the glucose-and energy-metabolism pathways and prostate cancer : interplay with antidiabetic drug usage

  Teemu Murtola (Speaker), Anssi Auvinen (Speaker), Johanna Schleutker (Speaker) & Teuvo Tammela (Speaker)

  22 Aug 2013

  Activity: Talk or presentation › Conference presentation